← Back to Search

Link2CARE for HIV/AIDS

N/A
Waitlist Available
Led By Katherine Elkington, PhD
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Young Adults
Between 18-24 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3-, 6-, and 12-month follow-ups
Awards & highlights

Study Summary

This trial is testing a new service delivery model for justice-involved young adults that integrates evidence-based protocols for HIV and STI testing, onsite intervention, and cross-system linkage to care.

Eligible Conditions
  • HIV/AIDS
  • Human Immunodeficiency Virus Infection
  • Substance Abuse
  • Substance Use Disorder
  • Sexually Transmitted Infections

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3-, 6-, and 12-month follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3-, 6-, and 12-month follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Months
Secondary outcome measures
Acceptance of HIV Testing (Yes/no)
Acceptance of STI Testing (Yes/no)
Any HIV Testing
+6 more
Other outcome measures
Number of HIV+ Young Adults Attending at Least One Treatment Appointment
Number of HIV+ Young Adults Referred to HIV Treatment
Number of Young Adults Behaviorally PrEP Eligible Attending at Least One HIV Care Appointment
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Link2CAREExperimental Treatment1 Intervention
This arm is comprised of participants randomized to the 4-session Link2CARE intervention.
Group II: Standard of CareActive Control1 Intervention
This arm is comprised of participants who will not receive the 4-session Link2CARE intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Link2CARE
2017
N/A
~310

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
474 Previous Clinical Trials
152,950 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,447 Previous Clinical Trials
2,593,759 Total Patients Enrolled
The National Center on Addiction and Substance Abuse at Columbia UniversityOTHER
9 Previous Clinical Trials
2,863 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~42 spots leftby Mar 2025